• Product NameOCC-1 Antibody
• Host SpeciesRabbit
• ClonalityPolyclonal
• PurificationAffinity chromatography purified via peptide column
• ApplicationsELISA WB IHC
• Species ReactivityHu
• Immunogen TypePeptide
• Immunogen DescriptionRaised against a 16 amino acid peptide near the amino terminus of human OCC-1.
• Target NameOCC-1
• Alternative Names    Overexpressed in colon carcinoma-1
• Accession No. Swiss-Prot:Q8TAD7
  Gene ID:387882
• UniprotQ8TAD7
• Gene ID387882;
• Concentration 1mg/ml
• Formulation Supplied in PBS containing 0.02% sodium azide.
• Storage Can be stored at -20˚C, stable for one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

OCC-1 (Overexpressed in colon carcinoma-1) was initially identified as a novel human cDNA overexpressed in a colon carcinoma cell line. Elevated levels of OCC-1 mRNA were observed in three of eight colon carcinomas, suggesting that OCC-1 may be a hallmark of only a subset of colon carcinomas. It is highly expressed in skeletal muscle, kidney, placenta, and pancreas tissues, with low to no expression in heart, brain, lung and liver tissues. At least two different OCC-1 mRNA species are known to exist.

• Western blot analysis of OCC-1 in human spleen tissue lysate with OCC-1 antibody at 2 ug/mL.
• Immunohistochemistry of OCC-1 in human spleen tissue with OCC-1 antibody at 2.5 ug/mL.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting